RESUMEN
AIM: To assess the effectiveness of the collagen biomaterial in treatment process in patients with DFS. MATERIAL AND METHODS: 71 patients 30-80 y.o. with diabetic foot syndrome of varying severity were included in prospective multicenter study. Patients were randomized into two homogeneous groups: control group (n=35) - standard therapy, other 36 patients (main group) were additionally treated with medical device (MD) Collost in accordance with the instructions for use. RESULTS: Biomaterial Collost using in complex treatment of diabetic foot syndrome resulted in more rapid and effective healing of the ulcer. The treatment success increased from 43% to 72%. Complete epithelialization was achieved by 2.6 times more rapidly in conjunction with reduction the incidence of unsuccessful treatment results by 4.1 times.
Asunto(s)
Colágeno , Pie Diabético , Repitelización/efectos de los fármacos , Anciano , Materiales Biocompatibles/administración & dosificación , Materiales Biocompatibles/farmacocinética , Disponibilidad Biológica , Colágeno/administración & dosificación , Colágeno/farmacocinética , Pie Diabético/diagnóstico , Pie Diabético/tratamiento farmacológico , Pie Diabético/fisiopatología , Monitoreo de Drogas/métodos , Femenino , Humanos , Masculino , Persona de Mediana Edad , Índice de Severidad de la Enfermedad , Tratamiento de Tejidos Blandos/métodos , Resultado del TratamientoRESUMEN
The article discusses the current quality control system in the psychiatric care in The Netherlands which has become a result of the involvement of various stakeholders, such as the state and the legislation, insurance companies, patients and their representatives, and the professionals. It can be seen that the influence of the psychiatrists has been rather limited, but their role can increase as the newly established Dutch Association of Medical Specialists will be gaining more weight and participate in the major decisions affecting the health care in the Netherlands.